Genevieve S Incefy

Title: Genevieve S Incefy: Innovator in Radioimmunoassays

Introduction: Genevieve S Incefy is an accomplished inventor based in New York, NY, known for her contributions to the field of biochemical research. With her innovative spirit, she has developed technologies that significantly enhance our understanding of biological processes.

Latest Patents: In her remarkable career, Genevieve holds one patent titled "Radioimmunoassays for the serum thymic factor (FTS)." This patent discloses methods for quantifying serum thymic factor, a critical thymic peptide hormone. The assay utilizes a specific antibody for FTS, either a monoclonal antibody or one derived from the antiserum of a host animal, alongside synthetic FTS or its analogs as standards. Additionally, it incorporates a radiolabeled FTS analogue as the tracer. Genevieve has also devised a method for treating serum or other biological fluids prior to the assay to eliminate interfering substances.

Career Highlights: Genevieve has established her career at the Sloan-Kettering Institute for Cancer, where she conducts groundbreaking research that merges biochemistry and immunology. Her work not only demonstrates her innovative capabilities but also has vital implications for cancer research and treatment.

Collaborations: Throughout her tenure at the Sloan-Kettering Institute, Genevieve has collaborated with esteemed colleagues, including Bruce W Erickson and Kam-Fook Fok. These partnerships amplify the impact of her research and help drive advancements in medical science.

Conclusion: Genevieve S Incefy exemplifies the spirit of innovation in the field of biochemistry. Her patent on radioimmunoassays showcases her significant contributions to scientific research and highlights the potential applications of her work in cancer treatment and beyond. Through her collaborations and career at the Sloan-Kettering Institute, she remains a key figure in her field, inspiring future generations of inventors and scientists.